Background: We aimed to determine gender differences in outcomes and mortality in Korean stroke patients. Methods: We analyzed the demographics, risk factors, in-hospital mortality, functional outcomes at discharge, and any-cause mortality over a 5-year period for 18,364 Korean patients, and determined a cumulative mortality rate using Kaplan-Meier and Cox proportional hazards regression analyses to elucidate gender differences in stroke outcomes. Results: Women suffered strokes that were severer than those suffered by men. Although women had a lower risk of any-cause death than men, they exhibited poorer functional status at discharge. Conclusion: In Korea, women lived longer, but had greater disabilities after strokes than men, indicating the need to develop gender-specific interventions to improve stroke outcomes and reduce the disability burden in women.

Korea Centers for Disease Control and Prevention. Construction of National Surveillance System for Cardiovascular & Cerebrovascular Diseases. 2006.
US Census Bureau. Population projections. US interim projections by age, sex, race, and Hispanic origin: 2000–2050. Summary table 1a. http://www.Census.Gov/ipc/www/usinterimproj/ (accessed Sept 10, 2007).
Heart and Stroke Foundation of Canada: The growing burden of heart disease and stroke in Canada 2003. 1-896242-30-8 Ottawa, Canada, 2003.
Bousser MG: Stroke in women: The 1997 Paul Dudley white international lecture. Circulation 1999;99:463–467.
Reeves MJ, Bushnell C, Howard G, Gargano JW, Duncan PW, Lynch G, Khatiwoda A, Lisabeth L: Sex differences in stroke: Epidemiology, clinical presentation, medical care, and outcomes. Lancet Neurol 2008;7:915–926.
Holroyd-Leduc JM, Kapral MK, Austin PC, Tu JV: Sex differences and similarities in the management and outcome of stroke patients. Stroke 2000;31:1833–1837.
Arboix A, Oliveres M, Garcia-Eroles L, Maragall C, Massons J, Targa C: Acute cerebrovascular disease in women. Eur Neurol 2001;45:199–205.
Glader EL, Stegmayr B, Norrving B, Terent A, Hulter-Asberg K, Wester PO, Asplund K: Sex differences in management and outcome after stroke: A Swedish national perspective. Stroke 2003;34:1970–1975.
Di Carlo A, Lamassa M, Baldereschi M, Pracucci G, Basile AM, Wolfe CDA, Giroud M, Rudd A, Ghetti A, Inzitari D: Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: Data from a multicenter multinational hospital-based registry. Stroke 2003;34:1114–1119.
Roquer J, Campello AR, Gomis M: Sex differences in first-ever acute stroke. Stroke 2003;34:1581–1585.
Kapral MK, Fang J, Hill MD, Silver F, Richards J, Jaigobin C, Cheung AM; for the Investigators of the Registry of the Canadian Stroke N: Sex differences in stroke care and outcomes: Results from the registry of the Canadian Stroke Network. Stroke 2005;36:809–814.
Ayala C, Croft JB, Greenlund KJ, Keenan NL, Donehoo RS, Malarcher AM, Mensah GA: Sex differences in us mortality rates for stroke and stroke subtypes by race/ethnicity and age, 1995–1998. Stroke 2002;33:1197–1201.
Niewada M, Kobayashi A, Sandercock PA, Kaminski B, Czlonkowska A: Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the international stroke trial. Neuroepidemiology 2005;24:123–128.
Benatru I, Rouaud O, Durier J, Contegal F, Couvreur G, Bejot Y, Osseby GV, Ben Salem D, Ricolfi F, Moreau T, Giroud M: Stable stroke incidence rates but improved case-fatality in Dijon, France, from 1985 to 2004. Stroke 2006;37:1674–1679.
Sheikh K, Bullock CM: Effect of measurement on sex difference in stroke mortality. Stroke 2007;38:1085–1087.
Stansbury JP, Jia H, Williams LS, Vogel WB, Duncan PW: Ethnic disparities in stroke: Epidemiology, acute care, and postacute outcomes. Stroke 2005;36:374–386.
Lee BC, Roh JK: International experience in stroke registries: Korea stroke registry. Am J Prev Med 2006;31:243–245.
Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke definitions for use in a multicenter clinical trial: Toast: Trial of Org 10172 in acute stroke treatment. Stroke 1993;24:35–41.
Thorvaldsen P, Asplund K, Kuulasmaa K, Rajakangas AM, Schroll M: Stroke incidence, case fatality, and mortality in the WHO Monica project. Stroke 1995;26:361–367.
Olsen TS, Dehlendorff C, Andersen KK: Sex-related time-dependent variations in post-stroke survival-evidence of a female stroke survival advantage. Neuroepidemiology 2007;29:218–225.
Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O’Fallon WM, Wiebers DO: Ischemic stroke subtypes: A population-based study of functional outcome, survival, and recurrence. Stroke 2000;31:1062–1068.
Bonita R, Ford MA, Stewart AW: Predicting survival after stroke: A threeyear follow-up. Stroke 1988;19:669–673.
Loor HI, Groenier KH, Limburg M, Schuling J, Meyboom-de Jong B: Risks and causes of death in a community-based stroke population: 1 month and 3 years after stroke. Neuroepidemiology 1999;18:75–84.
Wilson PW, Kannel WB, Silbershatz H, D’Agostino RB: Clustering of metabolic factors and coronary heart disease. Arch Intern Med 1999;159:1104–1109.
Simpson CR, Wilson C, Hannaford PC, Williams D: Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care. Stroke 2005;36:1771–1775.
Reid JM, Dai D, Gubitz GJ, Kapral MK, Christian C, Phillips SJ: Gender differences in stroke examined in a 10-year cohort of patients admitted to a Canadian teaching hospital. Stroke 2008;39:1090–1095.
Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG, Wang DZ: Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals editorial comment. Stroke 2001;32:1832–1840.
Deng YZ, Reeves MJ, Jacobs BS, Birbeck GL, Kothari RU, Hickenbottom SL, Mullard AJ, Wehner S, Maddox K, Majid A; for the Paul Coverdell National Acute Stroke Registry Michigan Prototype I: IV tissue plasminogen activator use in acute stroke: Experience from a statewide registry. Neurology 2006;66:306–312.
Gargano JW, Wehner S, Reeves M: Sex differences in acute stroke care in a statewide stroke registry. Stroke 2008;39:24–29.
Schumacher HC, Bateman BT, Boden-Albala B, Berman MF, Mohr JP, Sacco RL, Pile-Spellman J: Use of thrombolysis in acute ischemic stroke: analysis of the nationwide inpatient sample 1999 to 2004. Ann Emerg Med 2007;50:99–107.
Bateman BT, Schumacher HC, Boden-Albala B, Berman MF, Mohr JP, Sacco RL, Pile-Spellman J: Factors associated with in-hospital mortality after administration of thrombolysis in acute ischemic stroke patients: An analysis of the nationwide inpatient sample 1999 to 2002. Stroke 2006;37:440–446.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.